Market News

Penn Capital Management Co Upped Holding in Blackhawk Network Hldgs (HAWK) by $2.18 Million as Stock Price Rose; As Myriad Genetics (MYGN) Valuation Rose, White Pine Capital Has Lowered by $376,740 Its Stake

Scott A. Bedford increased its stake in Blackhawk Network Hldgs Inc (HAWK) by 23.72% based on its latest 2017Q3 regulatory filing with the SEC. Penn Capital Management Co Inc bought 49,488 shares as the company’s stock rose 16.53% with the market. The hedge fund run by Scott A. Bedford held 258,160 shares of the finance company at the end of 2017Q3, valued at $11.41M, up from 208,672 at the end of the previous reported quarter. Penn Capital Management Co Inc who had been investing in Blackhawk Network Hldgs Inc for a number of months, seems to be bullish on the $2.54 billion market cap company. The stock increased 0.11% or $0.05 during the last trading session, reaching $44.7. About 1.28 million shares traded. Blackhawk Network Holdings, Inc. (NASDAQ:HAWK) has risen 34.41% since February 21, 2017 and is uptrending. It has outperformed by 17.71% the S&P500.

White Pine Capital Llc decreased its stake in Myriad Genetics Inc (MYGN) by 51.17% based on its latest 2017Q3 regulatory filing with the SEC. White Pine Capital Llc sold 10,465 shares as the company’s stock rose 13.21% with the market. The institutional investor held 9,985 shares of the health care company at the end of 2017Q3, valued at $361,000, down from 20,450 at the end of the previous reported quarter. White Pine Capital Llc who had been investing in Myriad Genetics Inc for a number of months, seems to be less bullish one the $2.36 billion market cap company. The stock increased 3.69% or $1.2 during the last trading session, reaching $33.75. About 429,208 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has declined 37.47% since February 21, 2017 and is downtrending. It has underperformed by 54.17% the S&P500.

Analysts await Myriad Genetics, Inc. (NASDAQ:MYGN) to report earnings on May, 1. They expect $0.27 earnings per share, 0.00% or $0.00 from last year’s $0.27 per share. MYGN’s profit will be $18.86 million for 31.25 P/E if the $0.27 EPS becomes a reality. After $0.31 actual earnings per share reported by Myriad Genetics, Inc. for the previous quarter, Wall Street now forecasts -12.90% negative EPS growth.

Among 20 analysts covering Myriad Genetics (NASDAQ:MYGN), 4 have Buy rating, 5 Sell and 11 Hold. Therefore 20% are positive. Myriad Genetics had 58 analyst reports since July 21, 2015 according to SRatingsIntel. On Wednesday, February 7 the stock rating was maintained by Jefferies with “Hold”. Cowen & Co maintained it with “Hold” rating and $2500 target in Monday, August 14 report. On Wednesday, November 4 the stock rating was maintained by Mizuho with “Neutral”. Bank of America downgraded Myriad Genetics, Inc. (NASDAQ:MYGN) on Friday, July 29 to “Underperform” rating. As per Tuesday, July 21, the company rating was initiated by Gabelli. On Wednesday, November 8 the stock rating was maintained by Morgan Stanley with “Underweight”. The company was downgraded on Monday, October 10 by Ladenburg Thalmann. The firm earned “Buy” rating on Wednesday, February 7 by BTIG Research. On Wednesday, August 10 the stock rating was maintained by Morgan Stanley with “Underweight”. Stephens maintained it with “Buy” rating and $45.0 target in Tuesday, January 2 report.

Investors sentiment decreased to 0.86 in Q3 2017. Its down 0.16, from 1.02 in 2017Q2. It dropped, as 33 investors sold MYGN shares while 72 reduced holdings. 28 funds opened positions while 62 raised stakes. 71.79 million shares or 8.95% less from 78.85 million shares in 2017Q2 were reported. Nuveen Asset Mngmt Ltd Liability Corporation reported 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Spark Inv Mngmt Limited Liability Corporation owns 178,100 shares or 0.35% of their US portfolio. Dekabank Deutsche Girozentrale accumulated 0.01% or 45,793 shares. Kbc Group Nv has 0% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 5,231 shares. The Wisconsin-based Northwestern Mutual Wealth has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Moreover, Ingalls & Snyder Llc has 0.1% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 53,599 shares. First Tru Advsrs Lp holds 11,780 shares or 0% of its portfolio. Camber Mgmt Ltd Liability Corporation has 2.00 million shares for 4.59% of their portfolio. Swiss Natl Bank owns 114,600 shares. Eqis Capital Mngmt owns 0.05% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 26,221 shares. Tocqueville Asset Lp holds 0.01% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN) for 35,099 shares. Acadian Asset Mgmt Ltd Co stated it has 0.3% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN). Cwm Limited Liability owns 376,860 shares. Thompson Siegel & Walmsley Ltd Limited Liability Company reported 328 shares stake. Principal Fincl Grp Inc holds 0.02% or 524,735 shares.

White Pine Capital Llc, which manages about $341.56 million and $39.55 billion US Long portfolio, upped its stake in Ishares Barclays 1 (CSJ) by 1,370 shares to 134,536 shares, valued at $14.17B in 2017Q3, according to the filing. It also increased its holding in Ishares Barclays Intermediate Credit Etf (CIU) by 1,275 shares in the quarter, for a total of 30,220 shares, and has risen its stake in Ishares Floating Rate Bond Etf (FLOT).

Since September 1, 2017, it had 0 insider purchases, and 8 selling transactions for $6.39 million activity. The insider MARSH RICHARD M sold 40,000 shares worth $1.53M. Shares for $248,925 were sold by GILBERT WALTER PHD. $201,000 worth of stock was sold by DREISMANN HEINRICH on Monday, December 11. HENDERSON JOHN T sold $909,040 worth of stock.

Among 14 analysts covering Blackhawk Network Holdings (NASDAQ:HAWK), 3 have Buy rating, 0 Sell and 11 Hold. Therefore 21% are positive. Blackhawk Network Holdings had 39 analyst reports since July 24, 2015 according to SRatingsIntel. Bank of America maintained the stock with “Neutral” rating in Thursday, July 20 report. The firm has “Neutral” rating given on Thursday, April 28 by Wedbush. As per Tuesday, October 17, the company rating was maintained by Argus Research. The rating was maintained by Argus Research with “Buy” on Wednesday, July 29. The stock of Blackhawk Network Holdings, Inc. (NASDAQ:HAWK) has “Buy” rating given on Thursday, February 25 by Deutsche Bank. The firm has “Outperform” rating by BMO Capital Markets given on Friday, October 13. Credit Suisse downgraded the shares of HAWK in report on Thursday, February 16 to “Neutral” rating. The rating was maintained by Bank of America with “Neutral” on Thursday, October 12. Citigroup downgraded the stock to “Neutral” rating in Tuesday, January 17 report. The firm has “Buy” rating given on Friday, July 22 by Bank of America.

Leave a Reply

Your email address will not be published. Required fields are marked *